As clinicians work to improve uptake and prevent HIV infection by prescribing pre-exposure prophylaxis (PrEP) to eligible patients, a team of investigators from the University of Buffalo surveyed pharmacist students about PrEP. The survey found that the students had a high awareness of the regimen and generally positive attitudes towards it. 

Among the 291 students enrolled in a doctor of pharmacy academic training program at the University of Buffalo surveyed between October and November 2017, there was overall high awareness of PrEP (91%) and 61% reported high familiarity with PrEP prescription guidelines.

However, these high awareness rates did not transfer into knowledge of PrEP. Survey results found that 55% of participants knew the daily dosing frequency and approved medication for PrEP (Truvada) and just 44.2% knew that HIV

Read More At Article Source | Article Attribution